1
|
Hunter DJ and Felson DT: Osteoarthritis.
BMJ. 332:639–642. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kamimura M, Nakamura Y, Uchiyama S,
Ikegami S, Mukaiyama K and Kato H: The pathophysiology and
progression of hip osteoarthritis accompanied with joint pain are
potentially due to bone alterations-follow-up study of hip oa
patients. Open Rheumatol J. 8:46–53. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Smith GN Jr: The role of collagenolytic
matrix metalloproteinases in the loss of articular cartilage in
osteoarthritis. Fron Biosci. 11:3081–3095. 2006. View Article : Google Scholar
|
4
|
Burrage PS, Mix KS and Brinckerhoff CE:
Matrix metalloproteinases: Role in arthritis. Front Biosci.
11:529–543. 2006. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Naito K, Takahashi M, Kushida K, Suzuki M,
Ohishi T, Miura M, Inoue T and Nagano A: Measurement of matrix
metalloproteinases (MMPs) and tissue inhibitor of
metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis:
Comparison with generalized osteoarthritis. Rheumatology (Oxford).
38:510–515. 1999. View Article : Google Scholar : PubMed/NCBI
|
6
|
Aida Y, Maeno M, Suzuki N, Shiratsuchi H,
Motohashi M and Matsumura H: The effect of IL-1beta on the
expression of matrix metalloproteinases and tissue inhibitors of
matrix metalloproteinases in human chondrocytes. Life Sci.
77:3210–3221. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kobayashi M, Squires GR, Mousa A, Tanzer
M, Zukor DJ, Antoniou J, Feige U and Poole AR: Role of
interleukin-1 and tumor necrosis factor alpha in matrix degradation
of human osteoarthritic cartilage. Arthritis Rheum. 52:128–135.
2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Shibata S, Aimi N and Watanabe M:
Paeoniflorin, a monoterpene glucoside of chinese paeony root.
Tetrahedron Lett. 5:1991–1995. 1964. View Article : Google Scholar
|
9
|
Gu X, Cai Z, Cai M, Liu K, Liu D, Zhang Q,
Tan J and Ma Q: Protective effect of paeoniflorin on inflammation
and apoptosis in the cerebral cortex of a transgenic mouse model of
Alzheimer's disease. Mol Med Rep. 13:2247–2252. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y,
Wang T, Xia YF, Dai Y and Wei ZF: Paeoniflorin suppresses TGF-β
mediated epithelial-mesenchymal transition in pulmonary fibrosis
through a Smad-dependent pathway. Acta Pharmacol Sin. 37:794–804.
2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hao J, Yang X, Ding XL, Guo LM, Zhu CH, Ji
W, Zhou T and Wu XZ: Paeoniflorin potentiates the inhibitory
effects of erlotinib in pancreatic cancer cell lines by reducing
ErbB3 phosphorylation. Sci Rep. 6:328092016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shi L, Teng H, Zhu M, Li C, Huang K, Chen
BI, Dai Y and Wang J: Paeoniflorin inhibits nucleus pulposus cell
apoptosis by regulating the expression of Bcl-2 family proteins and
caspase-9 in a rabbit model of intervertebral disc degeneration.
Exp Ther Med. 10:257–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chang Y, Jia X, Wei F, Wang C, Sun X, Xu
S, Yang X, Zhao Y, Chen J, Wu H, et al: CP-25, a novel compound,
protects against autoimmune arthritis by modulating immune
mediators of inflammation and bone damage. Sci Rep. 6:262392016.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Thirion S and Berenbaum F: Culture and
phenotyping of chondrocytes in primary culture. Methods Mol Med.
100:1–14. 2004.PubMed/NCBI
|
15
|
Hu PF, Chen WP, Tang JL, Bao JP and Wu LD:
Protective effects of berberine in an experimental rat
osteoarthritis model. Phytother Res. 25:878–885. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Hu PF, Chen WP, Tang JL, Bao JP and Wu LD:
Apelin plays a catabolic role on articular cartilage: In vivo and
in vitro studies. Int J Mol Med. 26:357–363. 2010.PubMed/NCBI
|
18
|
Liu H, Wang J, Wang J, Wang P and Xue Y:
Paeoniflorin attenuates Aβ1-42-induced inflammation and chemotaxis
of microglia in vitro and inhibits NF-κB- and VEGF/Flt-1 signaling
pathways. Brain Res. 1618:149–158. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang S and Liu W: Paeoniflorin inhibits
proliferation and promotes apoptosis of multiple myeloma cells via
its effects on microRNA29b and matrix metalloproteinase2. Mol Med
Rep. 14:2143–2149. 2016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Liu Q, Lin X, Li H, Yuan J, Peng Y, Dong L
and Dai S: Paeoniflorin ameliorates renal function in
cyclophosphamide-induced mice via AMPK suppressed inflammation and
apoptosis. Biomed Pharmacother. 84:1899–1905. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen C, Du P and Wang J: Paeoniflorin
ameliorates acute myocardial infarction of rats by inhibiting
inflammation and inducible nitric oxide synthase signaling
pathways. Mol Med Rep. 12:3937–3943. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
He DY and Dai SM: Anti-inflammatory and
immunomodulatory effects of paeonia lactiflora pall., a traditional
chinese herbal medicine. Front Pharmacol. 2:102011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li PP, Liu DD, Liu YJ, Song SS, Wang QT,
Chang Y, Wu YJ, Chen JY, Zhao WD, Zhang LL and Wei W: BAFF/BAFF-R
involved in antibodies production of rats with collagen-induced
arthritis via PI3K-Akt-mTOR signaling and the regulation of
paeoniflorin. J Ethnopharmacol. 141:290–300. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Jia Z and He J: Paeoniflorin ameliorates
rheumatoid arthritis in rat models through oxidative stress,
inflammation and cyclooxygenase 2. Exp Ther Med. 11:655–659. 2016.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Wu D, Chen J, Zhu H, Xiong XG, Liang QH,
Zhang Y, Zhang Y, Wang Y, Yang B and Huang X: UPLC-PDA
determination of paeoniflorin in rat plasma following the oral
administration of radix paeoniae alba and its effects on rats with
collagen-induced arthritis. Exp Ther Med. 7:209–217. 2014.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Yang N, Cui H, Han F, Zhang L, Huang T,
Zhou Y and Zhou J: Paeoniflorin inhibits human pancreatic cancer
cell apoptosis via suppression of MMP-9 and ERK signaling. Oncol
Lett. 12:1471–1476. 2016. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhao L, Chang Q, Huang T and Huang C:
Paeoniflorin inhibits IL1β-induced expression of inflammatory
mediators in human osteoarthritic chondrocyte. Mol Med Rep.
17:3306–3311. 2018.PubMed/NCBI
|
28
|
Burrage PS and Brinckerhoff CE: Molecular
targets in osteoarthritis: Metalloproteinases and their inhibitors.
Curr Drug Targets. 8:293–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
29
|
Jo H, Park JS, Kim EM, Jung MY, Lee SH,
Seong SC, Park SC, Kim HJ and Lee MC: The in vitro effects of
dehydroepiandrosterone on human osteoarthritic chondrocytes.
Osteoarthritis Cartilage. 11:585–594. 2003. View Article : Google Scholar : PubMed/NCBI
|
30
|
Tchetverikov I, Lohmander LS, Verzijl N,
Huizinga TW, TeKoppele JM, Hanemaaijer R and DeGroot J: MMP protein
and activity levels in synovial fluid from patients with joint
injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis.
64:694–698. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Goupille P, Jayson MI, Valat JP and
Freemont AJ: Matrix metalloproteinases: The clue to intervertebral
disc degeneration? Spine (Phila Pa 1976). 23:1612–1626. 1998.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Little CB, Barai A, Burkhardt D, Smith SM,
Fosang AJ, Werb Z, Shah M and Thompson EW: Matrix metalloproteinase
13-deficient mice are resistant to osteoarthritic cartilage erosion
but not chondrocyte hypertrophy or osteophyte development.
Arthritis Rheum. 60:3723–3733. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Li NG, Shi ZH, Tang YP, Wang ZJ, Song SL,
Qian LH, Qian DW and Duan JA: New hope for the treatment of
osteoarthritis through selective inhibition of MMP-13. Curr Med
Chem. 18:977–1001. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Daheshia M and Yao JQ: The interleukin
1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol.
35:2306–2312. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Martel-Pelletier J, Alaaeddine N and
Pelletier JP: Cytokines and their role in the pathophysiology of
osteoarthritis. Front Biosci. 4:D694–D703. 1999. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wu DQ, Zhong HM, Ding QH and Ba L:
Protective effects of biochanin A on articular cartilage: In vitro
and in vivo studies. BMC Complement Altern Med. 14:4442014.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Roman-Blas JA and Jimenez SA: NF-kappaB as
a potential therapeutic target in osteoarthritis and rheumatoid
arthritis. Osteoarthritis Cartilage. 14:839–848. 2006. View Article : Google Scholar : PubMed/NCBI
|
38
|
Rigoglou S and Papavassiliou AG: The NF-κB
signalling pathway in osteoarthritis. Int J Biochem Cell Biol.
45:2580–2584. 2013. View Article : Google Scholar : PubMed/NCBI
|
39
|
Ono R, Kaisho T and Tanaka T: PDLIM1
inhibits NF-κB-mediated inflammatory signaling by sequestering the
p65 subunit of NF-κB in the cytoplasm. Sci Rep. 5:183272015.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Wu H, Li W, Wang T, Shu Y and Liu P:
Paeoniflorin suppress NF-kappaB activation through modulation of I
kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human
gastric carcinoma cells. Biomed Pharmacother. 62:659–666. 2008.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Huch K, Stove J, Puhl W and Gunther KP:
Review and comparison of culture-techniques for articular
chondrocytes. Z Orthop Ihre Grenzgeb. 140:145–152. 2002.(In
German). View Article : Google Scholar : PubMed/NCBI
|